MCLEAN, Va.--(EON: Enhanced Online News)--Alion Science and Technology, today announced that the Alion Council on Accreditation has awarded its Human Research Protection Program (HRPP) accreditation to the University of Nebraska Medical Center (UNMC), an academic medical center in Omaha, Nebraska affiliated with the University of Nebraska.
“UNMC’s achievement of Alion HRPP Accreditation is a testament to the sophistication of their research program. Among other notable accomplishments, UNMC has paired Alion HRPP Accreditation with their selection as one of only 14 DoD-sponsored University Affiliated Research Centers. That combination allows them to deliver a unique and enviable offering.”
The HRPP accreditation is a process that reviews the practices of organizations involved with research that involves human subjects and measures a program’s compliance to Alion’s comprehensive set of standards. Alion HRPP Accreditation Services is a commercial outgrowth of similar work the company has been providing to the U.S. federal government.
Programs at UNMC accredited by Alion encompass both academic and clinical units. Academic units of UNMC include the Colleges of Medicine, Dentistry, Nursing, Pharmacy, Public Health and the School of Allied Health Professions, Graduate Medical Education and several research institutes. Clinical facilities include the Nebraska Medical Center, Children’s Hospital and Medical Center and other hospitals. UNMC has strong research programs in the areas of cancer, neuroscience, cardiovascular disease, infections disease, genetics, drug development and nanomedicine, and rural and other health disparities.
UNMC was accredited because of their excellent policies, procedures and practices for protecting human subjects and its commitment to high ethical standards and regulatory compliance in research, according to Stephen Crawford, Alion HRPP Accreditation Services Executive Director. The Alion Council on Accreditation also recognized two Exemplary Practices of UNMC, the exceptional leadership of the Institutional Official (Alion Standard #1) and the excellent policies and procedures for reviewing, developing and utilizing specimen and data repositories (Alion Standard #28).
Crawford said, “UNMC’s achievement of Alion HRPP Accreditation is a testament to the sophistication of their research program. Among other notable accomplishments, UNMC has paired Alion HRPP Accreditation with their selection as one of only 14 DoD-sponsored University Affiliated Research Centers. That combination allows them to deliver a unique and enviable offering.”
About the Alion HRPP Accreditation Program
Alion launched its accreditation services in June, 2013 due to overwhelming interest in its innovative HRPP accreditation program and progressive Standards. The Alion HRPP Accreditation program features experienced staff, a client-friendly philosophy and a flexible yet rigorous accreditation process. Alion’s Council on Accreditation consists of six recognized experts in the field of human research protection and research ethics. For information about the Alion HRPP Accreditation Services email info@AlionHRPP.com or visit www.AlionHRPP.com.
About Alion Science and Technology
Alion Science and Technology delivers advanced engineering, IT and operational solutions to strengthen national security and drive business results. For customers in defense, civilian government and commercial industries, Alion’s engineered solutions support smarter decision-making and enhanced readiness in rapidly-changing environments. Building on over 75 years of innovation, Alion turns obstacles into opportunities to help customers achieve their missions. For more information, visit www.alionscience.com.
This press release contains information about management’s view of Alion’s future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of a variety of risk factors and uncertainties discussed in documents periodically filed by Alion with the SEC. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.